The vaccination campaign is going on in full swing in the country amid the Corona epidemic. Meanwhile, another good news is coming about vaccination in the country. DCGI has given approval for the study of mixed doses of Covishield and Covaccine in the country on behalf of the government. The Drug Controller General of India has given permission to conduct a study on the mixed dosage of Covaccine and Covishield.
It is believed that the mixed dose of Covishield and Covaxin will prove to be more effective against the corona virus. Recently, permission for approval was sought regarding this.
So far four vaccines have been approved in the country
India has approved four vaccines so far. AstraZeneca and Oxford’s Covishield in India, India Biotech’s Covaccine, Russia’s Sputnik V. In addition, Johnson & Johnson has been approved. According to sources, this week the fifth vaccine in the country, Zydus Cadila’s vaccine, may get approval for emergency use. But in the country, two vaccines, Covishield and Covaxin, are being used the most. Let us tell you that the work of vaccination has started in the country from January. Initially, the vaccine was given to health workers first and then to the elderly. Now all people above 18 years of age are being vaccinated in the country.
Mix dose of vaccine is more effective
Indian Council of Medical Research ([आइसीएमआर)] Studying on a mixed dose of Covishield and Covaccine, the results were surprising. It was found that people who were given one dose of Covishield and the other of Covaccine had higher immunity against the corona virus in their body than those who were given both doses of Covishield or Covaccine. That is, the mixed dose was found to be more effective. This has given impetus to the studies being done around the world regarding mixed dosage.